CD8A and neoplasm: Meanwhile, the inhibition in HDAC3 of CD8+T cells by butyrate and propionate, promotes the gene expression of effector molecules, such as IFN-γ and granzyme B, which can enhance the anti-tumor effect of the host, and improves the response to chemotherapy (79, 80).